Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy
Frontiers in Pharmacology · 24.07.2026 · 17
DOI: 10.3389/fphar.2026.1872108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.07.2026. Verfasst von Daniele Canarutto und 23 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Accurate prediction of busulfan exposure is critical to achieve target myeloablative exposure while minimizing toxicity in pediatric hematopoietic stem cell transplantation. Model-informed precision dosing is recommended for improved accuracy and flexibility; dose adjustments in clinical practice are frequently performed using linear proportionality between dose changes and area under the concentration–time curve (AUC), optionally accounting for decrease of busulfan clearance over time. We retrospectively analyzed 54 consecutive pediatric patients receiving once-daily intravenous busulfan with therapeutic drug monitoring to characterize the relationship between dose adjustments and AUC variations, and to explore determinants of acute toxicity. Correlation between dose adjustments and AUC variations was linear for dose changes up to 1.16-fold, but linearity underestimated AUC increases following larger dose escalations. A quadratic model better described the dose–AUC relationship, particularly for dose increases, and was supported by an inverse correlation between dose variation and clearance change. While cumulative AUC was consistently maintained within target ranges, higher peak single-dose AUCs were associated with increased acute toxicity, including longer duration of mucositis and greater parenteral nutrition requirements. Initial dosing at 80 mg/m 2 was associated with lower peak AUCs and reduced need for subsequent dose corrections compared with 120 mg/m 2 , without differences in engraftment outcomes. These findings highlight the clinical relevance of non-linear dose–exposure relationships and peak exposure in busulfan-related toxicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
- San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy.
- Pediatric Immunohematology Unit and BMT Program, IRCCS Ospedale San Raffaele, Milan, Italy.
- Diagnostic Medicine Department: Clinical Chemistry Laboratory, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Biomedicine and Prevention, PhD Program In Immunology, Molecular Medicine and Applied Biotechnologies, University of Rome Tor Vergata, Rome, Italy.
Zitieren
APA
Canarutto, D., De Gregori, S., Recupero, S., Tucci, F., Fumagalli, F., Gallo, V., Ferrua, F., Barzaghi, F., Migliavacca, M., Consiglieri, G., Cossutta, M., Doglio, M., Cenciarelli, S., Nonis, A., Facchini, M., Clerici, A., Jofra Hernandez, R., Locatelli, S., Albertazzi, E., …, & Calbi, V. (2026). Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1872108
Vancouver
Canarutto D, De Gregori S, Recupero S, Tucci F, Fumagalli F, Gallo V, et al. Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1872108
BibTeX
@article{Canarutto2026,
author = {Canarutto, Daniele and De Gregori, Simona and Recupero, Salvatore and Tucci, Francesca and Fumagalli, Francesca and Gallo, Vera and Ferrua, Francesca and Barzaghi, Federica and Migliavacca, Maddalena and Consiglieri, Giulia and Cossutta, Matilde and Doglio, Matteo and Cenciarelli, Sabina and Nonis, Alessandro and Facchini, Marcella and Clerici, Alessandra and Jofra Hernandez, Raisa and Locatelli, Sara and Albertazzi, Elena and Bartoli, Antonella and Cicalese, Maria Pia and Bernardo, Maria Ester and Aiuti, Alessandro and Calbi, Valeria},
title = {Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1872108}
}
EUVIMED